Items Tagged ‘Esophageal Cancer’

October 3rd, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer

By

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News


September 25th, 2017

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

By

Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this new indication must have PD-L1-expressing tumors, and must demonstrate disease progression after two or more prior lines of therapy – including fluoropyrimidine- and platinum-containing chemotherapy and, in some cases, HER2/neu-targeted […]

View full entry

Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News, pembrolizumab, Precision Cancer Medicine


December 8th, 2016

Should HER2 Testing Be Routinely Performed in Patients with Gastric Cancer?

By

The short answer is yes! New evidence-based guidelines for human epidermal growth factor receptor 2 (HER2) testing in advanced gastric and gastroesophageal adenocarcinoma (GEA) have been released jointly by the College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP), and American Society of Clinical Oncology (ASCO). Currently, HER2 is the only marker that can be […]

View full entry

Tags: adenocarcinoma, American Society for Clinical Pathology, and American Society of Clinical Oncology, asco, ASCP, CAP, College of American Pathologists, Esophageal Cancer, for human epidermal growth factor receptor 2, Gastric Cancer, Gastroesophageal cancer, HER2 testing


November 20th, 2016

It’s GERD Awareness Week–November 20th

By

It’s that time of year again when there is a tendency to overindulge in a mélange of delicious foods. Although many people may only suffer discomfort from over eating, another group of people suffer from the far more troublesome and chronic disorder of GERD—and it isn’t just over the holidays, nor is it simply from […]

View full entry

Tags: barrett's esophagus, Esophageal Cancer, GERD, heartburn, News, online community, Screening/Prevention Esophageal Cancer


May 9th, 2016

Another Study Confirms That Daily Aspirin Lowers Risk of Colorectal & Other GI Tract Cancers

By

The regular use of aspirin significantly reduces the overall risk of cancer, especially colorectal and other gastrointestinal tract cancers, according to a study published in JAMA Oncology.1 The recent report supports the results of previous clinical studies that have also demonstrated that the daily use of aspirin reduces the risk of death from several common cancers, including lung, […]

View full entry

Tags: aspirin, benefit, cancer, Colon Cancer, colorectal, daily, Esophageal Cancer, gastrointestinal, lung, Lung Cancer, News, Rectal Cancer


August 25th, 2015

Patients Rising, Launched to Fight for Access to Vital Therapies and Services for Patients with Life-Threatening Diseases

By

Patient advocacy veterans Jonathan and Terry Wilcox today announced the launch of a new not-for-profit organization, Patients Rising. This patient advocacy organization will educate, advocate and communicate the importance of access to vital therapies and services for patients who face life-changing and life-threatening diseases. The organization will be focused on ensuring that the patients’ voice […]

View full entry

Tags: All Cancer Types, Esophageal Cancer, News, Stage IV/Recurrent Esophageal Cancer, Types of Cancer, vital options


May 12th, 2015

Regular Screening of Barrett’s Esophagus Patients Improves Rate of Early Cancer Detection

By

Patients with Barrett’s esophagus who undergo regular exams have an improved chance that precancerous changes and esophageal cancer will be detected early. These findings were published in the journal Gut. Barrett’s esophagus is a pre-cancerous condition of the esophagus. It means that there is a type of cell called columnar epithelial cells present in the […]

View full entry

Tags: barrett's esophagus, Barrett's Esophagus Esophageal Cancer, early detection, endoscopic surveillance, Esophageal Cancer, News, Screening/Prevention Esophageal Cancer


April 15th, 2015

Radiofrequency Ablation in Barrett’s Esophagus May Prevent Esophageal Cancer

By

Treatment of Barrett’s esophagus with radiofrequency ablation appears to keep the condition from progressing to esophageal cancer. These findings were published in the Journal of the American Medical Association. Barrett’s esophagus is a pre-cancerous condition of the esophagus. It means that there is a type of cell called columnar epithelial cells present in the surface […]

View full entry

Tags: barrett's esophagus, Barrett's Esophagus Esophageal Cancer, Esophageal Cancer, News, prevention, radiofrequency ablation, Screening/Prevention Esophageal Cancer


March 26th, 2015

Cytosponge Offers Minimally Invasive Screening Option for Barrett’s Esophagus

By

Screening for Barrett’s esophagus with a new device called a Cytosponge is accurate compared to endoscopy but less expensive and easier on patients. These findings were reported in the journal PLoS Medicine. Barrett’s esophagus is a pre-cancerous condition of the esophagus. It means that there is a type of cell called columnar epithelial cells present […]

View full entry

Tags: barrett's esophagus, Barrett's Esophagus Esophageal Cancer, cytosponge, Esophageal Cancer, News


February 12th, 2015

AMG 337 MET Inhibitor Produces Impressive, Rapid Response in Gastric and Esophageal Cancers

By

AMG 337 is a novel small-molecule MET inhibitor that appears to show promise in the treatment of MET-amplified gastroesophageal junction, gastric, and esophageal cancers. MET inhibitors are a class of small molecules that inhibit the enzymatic activity of the c-Met tyrosine kinase. These inhibitors may have therapeutic application in the treatment of various types of […]

View full entry

Tags: AMG 337, Esophageal Cancer, esophagus, Gastric Cancer, gastroesophageal junction, Gastrointestinal Cancer, GI tumors, MET inhibitor, News, Recurrent Gastric Cancer, Stage IV/Recurrent Esophageal Cancer, Stages III-IV Gastric Cancer


December 4th, 2014

Esophageal Cancer Survival Improved Using Targeted Therapy Developed in Lung Cancer

By

Targeted therapy commonly used in lung cancer improves survival of esophageal cancer patients according to clinical trial results recently presented at the National Cancer Research Institute (NCRI) Cancer Conference in the UK. The esophagus is a muscular tube that food and liquids pass through on their on their way to the stomach. Each year in the […]

View full entry

Tags: EGFR, Esophageal Cancer, iressa, News, Stage IV/Recurrent Esophageal Cancer


November 13th, 2014

FDA Approves Cyramza™ in Combination With Paclitaxel for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

By

(CancerConnect) The U.S. Food and Drug Administration(FDA) has approved Cyramza™ (ramucirumab) for use in combination with paclitaxel for the treatment of patients with advanced gastric or gastroesophageal junction adenocarcinoma. Cyramza was approved in April 2014 as a single agent for the treatment of patients with advanced gastric or gastroesophageal junction adenocarcinoma refractory to or progressive […]

View full entry

Tags: cyramza, Esophageal Cancer, Gastric Cancer, News, paclitaxel, Recurrent Gastric Cancer, Stage IV/Recurrent Esophageal Cancer, Stages III-IV Gastric Cancer


August 18th, 2014

Scientific Review Suggests Aspirin Significantly Cuts Cancer Rates

By

A recent review of several studies confirms that taking a small daily dose of aspirin significantly reduces the risk of developing – or dying from several kinds of cancer.(1) Several clinical studies have suggested that aspirin can reduce the risk of colon, and other cancer’s of the gastrointestinal tract. (2,3,4) In order to study this […]

View full entry

Tags: aspirin, cancer prevention, Colon Cancer, Esophageal Cancer, Gastric Cancer, News, Screening/Prevention Colon Cancer, Screening/Prevention Esophageal Cancer, Screening/Prevention Gastric Cancer


December 4th, 2013

Minimally Invasive Endoscopic Procedure Effective in Early Esophageal Cancer

By

A minimally invasive endoscopic procedure to remove superficial, early stage esophageal is as effective as surgery that removes the entire esophagus, according to the results of a study published in Clinical Gastroenterology and Hepatology. The esophagus is a muscular tube that food and liquids pass through on their on their way to the stomach. Each year […]

View full entry

Tags: Barrett's Esophagus Esophageal Cancer, Esophageal Cancer, News, Stages I-III Esophageal Cancer


September 16th, 2013

End-of-Life Care Remains Aggressive, Despite Patient Wishes

By

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive intensive treatment until the last month of life and hospice care is often delayed until the final three […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, HIV Related Cancers